Dirk-Jan van Den Berg

Dirk-Jan van Den Berg

Auto-generated profile, based on publicly available information

Dirk-Jan van Den Berg

Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1996 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SASaskia A.B.E. Van Acker
Saskia A.B.E. Van Acker
DBDirk-Jan Van Den Berg
Dirk-Jan Van Den Berg
MTMichèl N.J.L. Tromp
Michèl N.J.L. Tromp
DGDésirée H. Griffioen
Désirée H. Griffioen
WBWout P. Van Bennekom
Wout P. Van Bennekom
ABAalt Bast
Aalt Bast

1 January 1996 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
SASaskia A. B. E. van Acker
Saskia A. B. E. van Acker
MGMarcel J. de Groot
Marcel J. de Groot
DBDirk-Jan van Den Berg
Dirk-Jan van Den Berg
MTMichèl N. J. L. Tromp
Michèl N. J. L. Tromp
GKGabrielle Donné-Op Den Kelder
Gabrielle Donné-Op Den Kelder
ABAalt Bast
Aalt Bast

1 February 2000 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Jan WijnholdsJan Wijnholds
Jan Wijnholds
ELElizabeth De Lange
Elizabeth De Lange
GSGeorge L. Scheffer
George L. Scheffer
DBDirk-Jan van Den Berg
Dirk-Jan van Den Berg
CMCarla A.A.M. Mol
Carla A.A.M. Mol
PBPiet Borst
Piet Borst
Multidrug resistance protein 1 (MRP1) is a transporter protein that helps to protect normal cells and tumor cells against the influx of certain xenobiotics. We previously showed that Mrp1 protects against cytotoxic drugs at the testis-blood barrier, the oral epithelium, and the kidney urinary collecting duct tubules. Here, we generated Mrp1/Mdr1a/Mdr1b triple-knockout (TKO) mice, and used them together with Mdr1a/Mdr1b double-knockout (DKO) mice to study the contribution of Mrp1 to the tissue distribution and pharmacokinetics of etoposide. We observed increased toxicity in the TKO mice, which accumulated etoposide in brown adipose tissue, colon, salivary gland, heart, and the female urogenital system. Immunohistochemical staining revealed the presence of Mrp1 in the oviduct, uterus, salivary gland, and choroid plexus (CP) epithelium. To explore the transport function of Mrp1 in the CP epithelium, we used TKO and DKO mice cannulated for cerebrospinal fluid (CSF). We show here that the lack of Mrp1 protein causes etoposide levels to increase about 10-fold in the CSF after intravenous administration of the drug. Our results indicate that Mrp1 helps to limit tissue distribution of certain drugs and contributes to the blood-CSF drug-permeability barrier.

1 October 1998 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SASaskia A.B.E van Acker
Saskia A.B.E van Acker
GBGeorgette Plemper van Balen
Georgette Plemper van Balen
DBDirk–Jan van Den Berg
Dirk–Jan van Den Berg
ABAalt Bast
Aalt Bast
WVWim J.F van der Vijgh
Wim J.F van der Vijgh

1 May 2008 in Journal of Controlled Release
Verified
Journal Article
Closed access
FVF.J. Verbaan
F.J. Verbaan
SBS.M. Bal
S.M. Bal
DBD.J. van Den Berg
D.J. van Den Berg
JDJ.A. Dijksman
J.A. Dijksman
MHM. van Hecke
M. van Hecke
JBJ.A. Bouwstra
J.A. Bouwstra

1 February 2007 in Journal of Controlled Release
Verified
Journal Article
Closed access
FVF.J. Verbaan
F.J. Verbaan
SBS.M. Bal
S.M. Bal
DBD.J. van Den Berg
D.J. van Den Berg
WGW.H.H. Groenink
W.H.H. Groenink
HVH. Verpoorten
H. Verpoorten
JBJ.A. Bouwstra
J.A. Bouwstra